Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Outset Medical, Inc. (NASDAQ:OM) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Outset insiders caused the company to misrepresent or fail to disclose that (1) the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved by the FDA; (2) that, as a resul ...